Background: Common 
INTRODUCTION
CVID, defined by panhypogammaglobulinemia and increased susceptibility to infections, has long been considered a category encompassing a heterogeneous group of primary immune system disorders. Most CVID patients exhibit a distinctive phenotype characterized by normal numbers of immunoglobulin-bearing B cell precursors but a deficiency of all immunoglobulin isotypes due to an arrest in plasma cell differentiation (reviewed in (1) ). Among a large group of CVID-and IgA-deficient patients, we observed that approximately two-thirds were associated with two ancestral extended MHC haplotypes, termed Haplotype I (HLA-DQB1*0201, HLA-DR of the glucose-6-phosphate-dehydrogenase (G6PD) locus of the active X-chromosome in blood cells, we determined that the female patient has clonal reticulocytes, platelets, granulocytes, and B and T lymphocytes. Conclusions: The simultaneous presence of globin synthesis abnormalities and panhypogammaglobulinemia suggests that a common insult at the stem cell level could contribute to the development of CVID and acquired thalassemia.
3, C4B-Sf, C4A-O, GIl-15, Bf-0.4, C2-a, HSP-7.5, TNFa-5, HLA-B8, HLA-A1) and Haplotype II (HLA-DQB 1*0201, HLA-DR7, C4B-S, C4A-L, G11-4.5, Bf-0.6, C2-b, HSP-9, TNFa-9, HLA-B44) (1) . The phenotypic similarities between selective IgA deficiency (IgAD) and CVID, the association of the same MHC haplotypes with both disorders (2) , and the intrafamilial occurrence of IgAD and CVID support the idea that IgAD and CVID may represent polar ends of a clinical spectrum of immunodeficiency that reflects a shared genetic susceptibility (2) .
Hb A is a tetrameric molecule formed by aand ,B-globin chains. Under normal circumstances, reticulocyte production of a-and ,B-globin is perfectly balanced (3 Hemoglobinopathy Evaluation Hemoglobinopathy evaluation, including globin chain synthesis, was performed using routine clinical laboratory procedures previously described (7).
Cell Preparations and DNA Studies For clonality studies, skin fibroblasts and myeloid cells were obtained and separated as previously described (8) . Lymphocyte subpopulations were isolated from peripheral blood by flow cytometric sorting of the nonadherent mononuclear cells for CD 19 (B lymphocytes) and CD3 (T lymphocytes) (8) . Hair was plucked from the scalp, and the roots were placed in sterile microtubes. The buccal mucosa was scrubbed with a sterile tongue depressor to obtain epithelial cells (8) .
Ligase detection reaction (LDR) analysis of the common nucleotide #1311 (C/T) exonic polymorphism of the X-linked gene G6PD was performed using 10 ng of genomic DNA or cDNA template prepared from total cellular RNA (8) .
Thermostable ligase (a kind gift of Dr. Francis Barany (9) ) was diluted in 10 Table 1 ) and at age 32 acquired progressive lymphadenopathy, which was due to a large cell follicular lymphoma of B-lineage cells. Hemoglobin electrophoresis was normal (see Table 1 ), and iron deficiency and sideroblastic anemias were excluded by biochemical studies and bone marrow morphology. Analysis of reticulocyte globin synthesis revealed an a// globin synthetic ratio of 1.4 (this ratio remained unchanged when repeated 3 weeks later at 1.42). This was diagnosed as an acquired 1 thalassemia, since both of his parents had normal 13-globin synthetic ratios and no evidence of red cell microcytosis or anemia (see Table 1 ). The proband and his mother have the HLA DR7-B44 extended haplotype (Haplotype II) previously found in one-third of our CVID patients (2) . The mother and father had normal serum immunoglobulin levels, and the father's paternity was confirmed by HLA studies.
Patient 2 (S25.59), a 26-year-old Caucasian female, began to experience recurrent sinopulmonary infections in her late teens, and panhypogammaglobinemia was discovered at age 23. She has inherited neither of the two MHC haplotypes associated with CVID in our patient population (2) . At the time of diagnosis of CVID she was anemic and microcytic (see Table 1 ), but In order to search for a common element in the pathogenesis of the acquired erythrocyte and lymphocyte defects in these patients, we performed clonality studies of mature hematopoietic progenitors in both thalassemic females. By examination of genomic DNA, only Patient 2 was found to be heterozygous for the X-chromosome G6PD #1311 C/T exonic polymorphism (7) . As shown in Fig. IA (Fig. IA (10) ). Analysis of T lymphocytes that had been isolated 1 year prior to the current study revealed that a small proportion of Patient 2's circulating T lymphocytes expressed the allelic 46 bp T transcript (Fig. 1A) . When B and T cell populations were isolated from the current mononuclear cell fraction, rtPCR LDR analyses (Fig. 1B) revealed the presence of only a single allele, suggesting that the proportion of the nonclonal T-cell population expressing the 46 bp T transcripts has disappeared over time.
DISCUSSION
This study establishes the presence of thalassemia in a significant proportion of patients with CVID. A review of previous red cell studies and an analysis of family members documented the acquired nature of this red cell disorder. The signs and symptoms of clonal disorders of hematopoiesis, such as myeloproliferative disorders, leukemias, and aplastic anemia, are due to defects in cells at the terminal stages of differentiation, but owe their genesis to mutation(s) at a progenitor cell level.
In females, one of the two X chromosomes is randomly inactivated early in ontogeny. The X chromosome inactivation phenomenon allows the detection of clonal hematopoiesis, since the active X chromosome will be the same in all the offspring of an altered progenitor cell. We have recently described an assay for the transcriptional polymorphism of X chromosome transcripts derived from the G6PD gene (8) , in which an exonic polymorphism (C/T) exists at position 1311 in all ethnic and racial groups. While the ratio of these transcripts is variable because of the random nature of X chromosome inactivation, we have not encountered a single allelic transcript in any normal tissue in contrast to the presence of a single transcript present in clonally derived tissues in the heterozygous women whom we have studied to date.
Using the ligase detection reaction, we were able to demonstrate clonal hematopoietic progeny of both myeloid and lymphoid cells in a patient with CVID and acquired thalassemia. (14) . Interestingly, regulation of globin transcription is mediated by factors that are not always erythroid specific but also operate on nonglobin genes in B cells and other tissues (15) . It could be hypothesized that a gene mutation in the hematopoietic pluripotent stem cell, the precursor of both lymphocytes and erythrocytes, could be associated with an abnormality of a transcription or regulatory factor that plays a major role in both globin gene expression and in B lymphocyte differentiation. Identification of this putative factor responsible for the acquired thalassemia may result not only in the understanding of one potential etiology for CVID but also in a better understanding of normal erythrocyte and lymphocyte differentiation.
